Q6FGL7 (Q6FGL7_HUMAN) Homo sapiens (Human)

Fatty acid-binding protein, liver UniProtKBInterProInteractive Modelling

127 aa; Sequence (Fasta) ; 4 identical sequences: Homo sapiens: P07148; Pan troglodytes: H2QIB0, A0A6D2WNW9; Pan paniscus: A0A2R9B589

Available Structures

37 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human liver FABP1 bound to tetrahydrocannabinolhomo-2-mer1-127
MLI;TCI;
Assess
Fabp protein after hvhomo-2-mer2-127
PLM;
Assess
Fabp ground state captured by XFELshomo-2-mer2-127
PLM;
Assess
Intermediate of FABP with a delay time of 30 nshomo-2-mer2-127
PLM;
Assess
Fabp protein before hvhomo-2-mer2-127
PLM;
Assess
A69C-M71L mutant of Fabp proteinhomo-2-mer2-127
PLM;
Assess
intermediate of FABP with a delay time of 100 nshomo-2-mer2-127
PLM;
Assess
intermediate of FABP with a delay time of 300 nshomo-2-mer2-127
PLM;
Assess
Intermediate of FABP with a delay time of 10 nshomo-2-mer2-127
PLM;
Assess
Crystal Structure of apo human FABP1 monoclinic form IIImonomer1-127
DMS;
Assess
Crystal Structure of apo human FABP1i monoclinic form II, twinned with beta=90degmonomer1-127
Assess
Crystal Structure of apo human FABP1 - monoclinic form Imonomer1-127
Assess
Crystal Structure of apo human FABP1 - orthorhombic formmonomer1-127
Assess
Crystal Structure of human FABP1 in complex with 2-[[4-cyclopropyl-5-methyl-3-[3-(trifluoromethyl)-…monomer1-127
VI9;SCN;
Assess
Crystal structure of human fatty acid binding protein 1 (FABP1)monomer1-127
Assess
Crystal Structure of human FABP1 in complex with 2-[[3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-…monomer1-127
WII;SCN;
Assess
NMR solution structure of wild type apo hFABP1 at 308 Kmonomer1-127
Assess
NMR solution structure of wild type hFABP1 with GW7647monomer1-127
Assess
NMR solution structure of wild type hFABP1 with GW7647monomer1-127
2VN;
Assess
Solution structure of human liver fatty acid binding proteinmonomer1-127
Assess
Structure of human LFABP at high resolution from S-SADmonomer2-127
PLM;
Assess
Iodide derivative of human LFABP at high resolutionmonomer2-127
PLM; 12×IOD;
Assess
Crystal Structure of human LFABP complex with two molecules of palmitic acid (holo-LFABP)monomer2-127
PLM;
Assess
Iodide derivative of human LFABPmonomer2-127
PLM;IOD;
Assess
Iodide derivative of human LFABPmonomer2-127
PLM;IOD;
Assess
Barium derivative of human LFABPmonomer2-127
PLM;BA;
Assess
Iodide derivative of human LFABPmonomer2-127
PLM;IOD;
Assess
Structure of human LFABP in complex with one molecule of palmitic acidmonomer2-127
PLM;
Assess
Cadmium derivative of human LFABPmonomer2-127
PLM;CD;
Assess
Barium derivative of human LFABPmonomer2-127
PLM;BA;IOD;
Assess
Iodide derivative of human LFABPmonomer2-127
PLM;IOD;
Assess
Iodide derivative of human LFABPmonomer2-127
PLM;IOD;
Assess
Cadmium derivative of human LFABPmonomer2-127
PLM;CD;
Assess
Structure of human LFABP (apo-LFABP)monomer2-127
Assess
Solution Structure of Human Holo L-FABPmonomer2-127
Assess
Solution Structure of Human Apo L-FABPmonomer2-127
Assess
Human L-FABP in complex with oleatemonomer2-127
OLA;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7fxo.2.Amonomer0.841-127
100.00
Assess
6e50.1.Amonomer0.741-127
30.16
Assess